Primary aldosteronism among newly diagnosed and untreated hypertensive patients in a Swedish primary care area

Scandinavian Journal of Primary Health Care

Volumn 29, Issue 1, 2011, Pages 57-62

  Westerdahl, Christina ^a   Bergenfelz, Anders ^a   Isaksson, Anders ^a   Nerbrand, Christina ^a   Valdemarsson, Stig ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Aldosterone; aldosterone to renin ratio; family practice; hypertension; primary aldosteronism; renin

Indexed keywords

ALDOSTERONE; DIAGNOSTIC AGENT; FLUDROCORTISONE; RENIN;

ADRENAL GLAND; ADULT; AGED; ARTICLE; BLOOD; BLOOD SAMPLING; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; RADIOGRAPHY;

ADRENAL GLANDS; ADULT; AGED; ALDOSTERONE; BLOOD SPECIMEN COLLECTION; FEMALE; FLUDROCORTISONE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; RENIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79951790216     PISSN: 02813432     EISSN: 15027724     Source Type: Journal    
DOI: 10.3109/02813432.2011.554015     Document Type: Article

References (32)

1. Jönsson B. Cost benefit of treating hypertension. J Hum Hypertens 1994;12:65-70.
2. Johannesson M. The cost-effectiveness of hypertension treatment in Sweden: An analysis of the criteria for intervention and choice of drug treatment. J Hum Hypertens 1999;10:23-6.
3. Stowasser M, Gordon RD. Primary aldosteronism. Best Pract Res Clin Endocrinol Metab 2003;17:591-605.
4. Young WF Jr. Primary aldosteronism: A common and curable form of hypertension. Cardiol Rev 1999;7:207-14. (Pubitemid 29316248)
5. Stowasser M, Gordon RD. Primary aldosteronism: From genesis to genetics. Trends Endocrinolol Metab 2003;14:310-7. (Pubitemid 37093128)
6. Young WF. Primary aldosteronism: Renaissance of a syndrome. Clin Endocrinolol 2007;66:607-18. (Pubitemid 46699525)
7. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, et al. Case detection, diagnosis and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline. J Clin Endocrinolo Metab 2008;93:3266-81.
8. Mattson C, Young WF jr. Primary aldosteronism: Diagnostic and treatment strategies. Nat Clin Pract Nephrol 2006;2:198-208.
9. Conn JW. Primary aldosteronism, a new clinical entity. J Lab Clin Med 1955;45:661-4.
10. Lim PO, Brennan G, Shiels P. Unexpectedly high prevalence of primary hyper-aldosteronism in a hypertensive population in Dundee. J Endocrinol 1998;156:22.
11. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM. Potentially high prevalence of primary hyperaldosteronism in a primary-care population. Lancet 1999;353:40. (Pubitemid 29037708)
12. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centres from five continents. J Clin Endocrinolo Metab 2004;89:1045-50. (Pubitemid 38368386)
13. Westerdahl C, Bergenfelz A, Isaksson A, Wihl A, Nerbrand C, Valdemarsson S. High frequency of primary aldosteronism among hypertensive patients from a primary care area in Sweden. Scand J Prim Health Care 2006;24:154-9. (Pubitemid 44272851)
14. Gordon RD, Stowasser M. Primary aldosteronism: The case for screening. Nat Clin Pract Nephrol 2007;3:582-3. (Pubitemid 350012823)
15. Stowasser M, Gordon RD, Gunasekera TG, Cowley DC, Ward G, Smithers BM. High rate of detection of primary aldosteronism, including surgically treatable forms, after "non selective" screening of hypertensive patients. J Hypertens 2003;2:2149-57.
16. Fogari R, Preti P, Zoppi A, Rinaldi A, Fogari E, Mugellini A. Prevalence of primary aldosteronism in unselected hypertensives: A prospective study based on the use of an aldosterone/renin ratio as a screening test. Hypertens Rev 2007;30:111-17. (Pubitemid 46541784)
17. Anis AY, White WB, Mansoor GA. Hyperaldosteronsim is a common cause of secondary hypertension missed by primary care physicians and associated with normokalemia. Am J Hypertens 1998;11:199A.
18. Seifarth C, Trenkel S, Schobel H, Hahn EG, Hensen J. Influence of antihypertensive medication on aldosterone and renin concentration in differential diagnosis of essential hypertension and primary aldosteronism. Clin Endocrinol 2002;57:457-65. (Pubitemid 35221345)
19. Rossi GP, Rossi E, Pavan E, Rosati N, Zecchel R, Semplicini A, et al. Screening for primary aldosteronsism with a logistic multivariate discriminant analysis. Clin endocrinol (Oxf.) 1998;49:713-23. (Pubitemid 29009500)
20. Mulatero P, Dluhy RG, Giachetti G, Boscaro M, Veglio F, Stewart PM. Diagnosis of primary aldosteronism: From screening to subtype differentiation. Trends Endocrinol Metab 2005;16:114-9. (Pubitemid 40432461)
21. Doppman J, Gill J. Hyperaldosteronism: Sampling adrenal veins. Radiology 1996;198: 309-12.
22. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005;45:1243-8. (Pubitemid 40523144)
23. Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 2008;168:80-5.
24. Mosso L, Carvajal C, Gonzá l ez A, Barraza A, Avila F, Montero J, Huete A, et al. Primary aldosteronism and hypertensive disease. Hypertension 2003;42:161-5.
25. Stowasser M, Gordon RD. Primary aldosteronism: Careful investigation is essential and rewarding. Molecular Cellular Endocrinolol 2004;217:33-9. (Pubitemid 38596626)
26. Seiler L, Rump L, Schulte-Mönting J, Slawik M, Borm K, Pavenstädt H, et al. Diagnosis of primary aldosteronism: Value of different screening parameters and influence of antihypertensive drugs. Eur J Endocrinol 2004;150:329-37. (Pubitemid 38443783)
27. Hennings J, Andreasson S, Botling J, Hägg A, Sundin A, Hellman P. Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism. Langenbeck's Arch Surg 2009;395:133-7.
28. Campagnacci R, Crosta F, De Sanctis A, Baldarelli M, Giacchetti G, Paganini AM, et al. Long-term results of laparoscopic adrenalectomy for primary aldosteronism. J Endocrinol Invest 2009;32:57-62.
29. Nishikawa T, Saito J, Omura M. Prevalence of primary aldosteronism: Should we screen for primary aldosteronism before treating hypertensive patients with medication? Endocrine J 2006;10:1507-19.
30. Montoni VM, Young W Jr. Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism: A systematic review of literature. Endocrionol Metab Clin Am 2002;31:619-32.
31. Rossi GP, Pessina, Heagerty AM, Primary aldosteronism: An update on screening, diagnosis and treatment. J Hypertens 2008;26:613-21. (Pubitemid 351354903)
32. Mulatero P, Monticone S, Bertello C, Tizzani D, Iannaccone A, Crudo V, Veglio F. Evaluation of primary aldosteronism. Curr Opin Endocrinol Diabetes Obes 2010b;17:188-93.